Organovo’s stock skyrocketed 244% Tuesday on the news. The deal sees Lilly pay out $9 million upfront plus another $1 million after 15 months to the San Diego biotech, according to Securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback